Hospitals worldwide are experiencing a shortage in essential intravenous sedative
medications. This is attributable to high number and high sedative needs of COVID-19 …

Background: Volatile sedation in the intensive care unit (ICU) may reduce the number of
adverse events and improve patient outcomes compared with intravenous (IV) sedation. We …

Management of patient sedation and analgesia to alleviate anxiety and pain and facilitate
mechanical ventilation is one of the key roles of every intensivist. During the coronavirus …

Purpose In this retrospective study, we compared inhaled sedation with isoflurane to
intravenous propofol in invasively ventilated COVID-19 patients with ARDS (Acute …

Inhaled sedation with halogenated agents, such as isoflurane or sevoflurane, is now
feasible in intensive care unit (ICU) patients through dedicated vaporisers and scavenging …

Background: Volatile anesthetics were used as sedative agents in COVID-19 (Coronavirus
Disease 2019) invasively ventilated patients for their potentially beneficial pharmacological …

Background Current intensive care unit (ICU) sedation guidelines recommend strategies
using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU …

Inhaled sedation was recently approved in Europe as an alternative to intravenous sedative
drugs for intensive care unit (ICU) sedation. The aim of this narrative review was to …

Background Volatile anesthetics are used more commonly for sedation in the intensive-care-
unit (ICU). However, evidence for long-term use remains low. We therefore conducted a …

Background The COVID-19 pandemic has increased the number of patients in ICUs leading
to a worldwide shortage of the intravenous sedative agents obligating physicians to find …